http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102185981-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 2019-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102185981-B1 |
| titleOfInvention | Nanovesicles derived from Streptococcus bacteria and Use thereof |
| abstract | The present invention relates to vesicles derived from bacteria of the genus Streptococcus and its use, and the present inventors provide clinical samples of patients with liver cancer, pancreatic cancer, breast cancer, cirrhosis, myocardial infarction, atrial fibrillation, diabetes, Parkinson's disease, dementia, and oral disease compared to normal people. The vesicles were significantly reduced in, and it was experimentally confirmed that when the vesicles isolated from the strain were administered, the secretion of inflammatory mediators by pathogenic vesicles such as E. coli-derived vesicles was significantly suppressed, and Streptococcus genus according to the present invention Bacterial vesicles are used to develop a method for diagnosing liver cancer, pancreatic cancer, breast cancer, cirrhosis, myocardial infarction, atrial fibrillation, diabetes, Parkinson's disease, dementia, and oral diseases, and a composition for preventing or treating the disease or inflammatory disease It can be usefully used. |
| priorityDate | 2018-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 192.